Brixmor (NYSE: BRX) is a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers. Its 363 retail centers comprise approximately 64 million square feet of prime retail space in established trade areas. The Company strives to own and operate shopping centers that reflect Brixmor's vision "to be the center of the communities we serve" and are home to a diverse mix of thriving national, regional and local retailers. Brixmor is a proud real estate partner to over 5,000 retailers including The TJX Companies, The Kroger Co., Publix Super Markets and Ross Stores.

Brixmor Property Group Inc.

Analysts have been eager to weigh in on the Real Estate sector with new ratings on Lineage, Inc. (LINE), Brixmor Property (BRX) and Alexandria Equi...

Analysts’ Opinions Are Mixed on These Real Estate Stocks: Lineage, Inc. (LINE), Brixmor Property (BRX) and Alexandria Equities (ARE)

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Brixmor Property (BRX) and CapitaLand Ascendas REIT...

Analysts Are Bullish on Top Real Estate Stocks: Brixmor Property (BRX), CapitaLand Ascendas REIT (ACDSF)

Moleculin Biotech ( ($MBRX) ) has shared an announcement. On April 23, 2026, Moleculin Biotech reported new preclinical data at the American Associ...

Moleculin Highlights Promising Preclinical Data for L-ANN

LB Pharmaceuticals, Inc. ($LBRX) announced an update on their ongoing clinical study. This Phase II clinical study, titled “A Randomized, Double Bl...

LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know

ImmunityBio (IBRX) is facing a securities lawsuit alleging that the company and Patrick Soon-Shiong overstated what Anktiva could do in promotional...

ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter

Belararox Ltd. ( ($AU:BRX) ) has provided an announcement. Belararox is advancing its TMT project in San Juan, Argentina, where successful drilling...

Belararox Targets Tier-1 Copper Discoveries in Argentina and Botswana

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mediwound (MDWD) and ImmunityBio (IBRX) with bullish...

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)

Forte Biosciences ( ($FBRX) ) has issued an announcement. On April 8, 2026, Forte Biosciences, Inc. priced a public offering of 5,709,936 shares of...

Forte Biosciences Prices $150 Million Public Offering

Belararox Ltd. ( ($AU:BRX) ) has issued an update. Belararox is intensifying drilling at the Toro Central prospect within its TMT Project in Argent...

Belararox Extends High-Grade Drilling Push at Argentina’s TMT Project

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX) and...

Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX)

ImmunityBio ( ($IBRX) ) just unveiled an update. On April 6, 2026, ImmunityBio, Inc. announced it had submitted a comprehensive response to a March...

ImmunityBio Addresses FDA Warning on ANKTIVA Promotion

Insiders have been trading these 5 stocks: (($IBRX)), (($KEYS)), (($RBRK)), (($AFL)) and (($MCO)). Here is a breakdown of their recent trades and t...

ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up

Belararox Ltd. ( ($AU:BRX) ) has issued an announcement. Belararox Ltd has relocated its corporate office, with its principal place of business now...

Belararox Relocates Corporate Office Without Changing Contact Details

Executive Accountability: Patrick Soon-Shiong Named in Securities Action NEW YORK, March 31, 2026 — Levi & Korsinsky, LLP notifies investors that D...

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Soon-Shiong Allegedly Overstated ANKTIVA Efficacy: Levi & Korsinsky

ImmunityBio (IBRX) is facing a securities lawsuit after investors alleged that public statements about Anktiva overstated its capabilities, includi...

Market Cap	$9.22B	P/E Ratio	12.98
52W High	$31.04	52W Low	$24.37
Div Yield	123.0%	Payout Ratio	90.8%
EPS Growth 3Y	2.2%	52W Position	92.0%
Overall Score	77	Value Score	100
Quality Score	50	Technical Score	81

EPS Current Est	$2.35	EPS Next Est	$2.47
EPS Growth Est	+5.1%	DPS Growth 3Y	6.8%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BRX	$30.50	+0.49%	2.59M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BRX	$30.50	+0.5%	2.59M
3
4
5
6

BRX

BRX

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Brixmor Property Group Inc. Data in Excel

Get Brixmor Property Group Inc. Data in Excel